A thorough investigation of the Muha Pharmaceuticals Master Case – specifically focusing on the compliance breaches and subsequent fallout – reveals a deeply concerning pattern of misconduct. The analysis highlights systemic failures across multiple sectors, including quality assurance and documentation. It's clear that company oversight was ei